MEN1 Foundation .org

Supporting awareness, personal research, and treatment of Multiple Endocrine Neoplasia Type 1

Pages

  • Home
  • References
  • Other resources
  • Who we are

September 2, 2014

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB–IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial : The Lancet Oncology
Posted by John F Robin
Email ThisBlogThis!Share to XShare to FacebookShare to Pinterest
Labels: adjuvant, chemotherapy, cisplatin, non-small cell lung cancer, radiation, treatment, vinorelbine

No comments:

Post a Comment

Newer Post Older Post Home
Subscribe to: Post Comments (Atom)

Translate

Search this blog

Tags

acquired resistance (1) adenoma (4) adjuvant (1) AXI (1) back pain (1) berberine (1) bone mineral density (1) breast (1) breast cancer (2) Bromocriptine (4) Cabergoline (9) calcium (2) cancer (8) cannabis (1) carcinoid syndrome (1) carcinoid tumor (3) cavernous sinus (1) chemotherapy (2) chromatin (5) cisplatin (1) colon (1) CRISPR (1) cure (2) DNA (6) dopamine (4) dopamine agonist (6) DRD2 (1) drug (9) editor's notes (2) endoscopic (1) epigenetic (7) Erivedge (1) everolimus (1) fertility (1) fetus (1) forearm (1) GAS1 (1) GAS6 (1) gene (5) gene therapy (2) genetic testing (1) GEP-NETs (1) Hedgehog signaling (1) hippocampus (1) histone (8) HOT (2) hypercalcemia (2) hyperparathyroidism (8) hyperprolactinemia (5) hypocalcemia (1) hypothalamus (1) immunotherapy (1) intestine (1) intragenic deletion (1) islet cell (2) Leutetium (1) liver (1) lung (1) macroprolactin (2) macroprolactinemia (1) malignancy (2) MEN1 (7) MEN1 Foundation (2) MEN1 gene (7) menin (20) metastasis (2) methylation (7) MLL (2) MRI (3) must read (1) NETs (2) neuroendocrine (1) non-small cell lung cancer (3) nonfunctioning (1) octreotide (1) outcome (1) overview (8) pancreas (7) parathyroid (5) parathyroid hormone (3) parathyroidectomy (2) Pasireotide (1) pediatric (3) PEG (1) PHPT (2) pituitary (20) PNET (1) PRMT5 (1) prolactin (8) prolactin receptor (2) prolactinoma (9) PRRT (1) PTH (1) pulmonary (1) radiation (3) radiotherapy (2) replication (2) research (1) resistance (6) screening protocol (4) sella (1) sleep (1) staging (2) stem cells (1) sternocleidomastoid (1) suggested books (2) sunitinib (1) surgery (9) Temozolomide (3) transcription (2) transplant (1) transsphenoidal (4) treatment (34) tumor (12) tumor suppression (8) tumorigenisis (3) vinorelbine (1) virus (1) Vitamin D (2) Whipple surgery (1) women (1)

Blog Archive

  • ►  2020 (1)
    • ►  March (1)
  • ►  2018 (3)
    • ►  October (2)
    • ►  August (1)
  • ►  2016 (4)
    • ►  October (1)
    • ►  February (1)
    • ►  January (2)
  • ►  2015 (2)
    • ►  February (2)
  • ▼  2014 (11)
    • ►  December (1)
    • ►  November (1)
    • ►  October (1)
    • ▼  September (8)
      • Minimally invasive, high-performance intervention ...
      • Bioengineered decoy protein may stop cancer from s...
      • Bronchopulmonary carcinoid in multiple endocrine n...
      • Non-small cell lung cancer staging -National Cance...
      • Non-small cell lung cancer (NSCLC) -general inform...
      • Carcinoid lung tumors – incidence, treatment and o...
      • Learning about Carcinoid Syndrome
      • Adjuvant vinorelbine plus cisplatin versus observa...
  • ►  2013 (13)
    • ►  November (1)
    • ►  September (3)
    • ►  August (2)
    • ►  July (1)
    • ►  June (1)
    • ►  May (1)
    • ►  April (1)
    • ►  March (2)
    • ►  January (1)
  • ►  2012 (60)
    • ►  November (2)
    • ►  October (3)
    • ►  September (3)
    • ►  August (1)
    • ►  July (1)
    • ►  June (4)
    • ►  May (33)
    • ►  March (1)
    • ►  February (4)
    • ►  January (8)

Popular Posts

  • MR-Linac Radiation Therapy: new cancer treatment technology at Froedtert Hospital, Milwaukee
    MR-Linac Radiation Therapy -One of only two sites in the U.S. offering this capability.
  • Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for MEN1?
    Primary Hyperparathyroidism in Young People. When Should We Perform Genetic Testing for Multiple Endocrine Neoplasia 1 (MEN-1)? T. Lassen,...
  • Chronic Inflammation and Gastroenteropancreatic Neuroendocrine Tumors
    The Association of Chronic Inflammation and Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) -Maja Cigrovski Berković, Davorka Herma...

Subscribe To

Posts
Atom
Posts
Comments
Atom
Comments

Followers

Total Pageviews

37,833

About Me

John F Robin
View my complete profile
Copyright 2012 MEN1 Foundation. Simple theme. Powered by Blogger.